EJCTS Click here to go to Edwards website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Alon S. Aharon
Davis C. Drinkwater, Jr
Paul Chang
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aharon, A. S.
Right arrow Articles by Chang, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aharon, A. S.
Right arrow Articles by Chang, P.
Related Collections
Right arrow Cerebral protection

Eur J Cardiothorac Surg 2004;26:912-919
© 2004 Elsevier Science NL


Cerebral activation of mitogen-activated protein kinases after circulatory arrest and low flow cardiopulmonary bypass

Alon S. Aharona, Matthew R. Mulloyb*, Davis C. Drinkwater, Jrb, Oliver B. Laob, Mahlon D. Johnsonb, Megan Thunderb, Chang Yub, Paul Changb

a Division of Cardiothoracic Surgery, St Louis University Health Sciences Center, 3635 Vista Avenue at Grand Boulevard, St Louis, MO 63110-0250, USA
b Vanderbilt University Medical Center, 1301 22nd Ave, Nashville, TN, USA

Received 16 November 2003; received in revised form 2 April 2004; accepted 5 May 2004.

* Corresponding author. Tel.: +1-615-343-9193
e-mail: mmulloy{at}utmem.edu

Objectives: Mitogen-activated protein kinases (MAPK) are important intermediates in the signal transduction pathways involved in neuronal dysfunction following cerebral ischemia-reperfusion injury. One subfamily, extracellular regulated kinase 1/2, has been heavily implicated in the pathogenesis of post-ischemic neuronal damage. However, the contribution of extracellular regulated kinase 1/2 to neuronal damage following deep hypothermic circulatory arrest and low flow cardiopulmonary bypass is unknown. We attempted to correlate the extent of neuronal damage present following deep hypothermic circulatory arrest and low flow cardiopulmonary bypass with phosphorylated extracellular regulated kinase 1/2 expression in the cerebral vascular endothelium. Methods: Piglets underwent normal flow cardiopulmonary bypass (n=4), deep hypothermic circulatory arrest (n=6) and low flow cardiopulmonary bypass (n=5). Brains were harvested following 24 h of post-cardiopulmonary bypass recovery. Cerebral cortical watershed zones, hippocampus, basal ganglia, thalamus, cerebellum, mesencephalon, pons and medulla were evaluated using hematoxylin and eosin staining. A section of ischemic cortex was evaluated by immunohistochemistry with rabbit polyclonal antibodies against phosphorylated extracellular regulated kinase 1/2. Results: Compared to cardiopulmonary bypass controls, the deep hypothermic circulatory arrest and low flow cardiopulmonary bypass piglets exhibited diffuse ischemic changes with overlapping severity and distribution. Significant neuronal damage occurred in the frontal watershed zones and basal ganglia of the deep hypothermic circulatory arrest group (P<0.05). No detectable phosphorylated extracellular regulated kinase 1/2 immunoreactivity was found in the cardiopulmonary bypass controls; however, ERK 1/2 immunoreactivity was present in the cerebral vascular endothelium of the deep hypothermic circulatory arrest and low flow cardiopulmonary bypass groups. Conclusions: Our results indicate that phosphorylated extracellular regulated kinase 1/2 may play a prominent role in early cerebral ischemia-reperfusion injury and endothelial dysfunction. The pharmacologic inhibition of extracellular regulated kinase 1/2 represents a new and exciting opportunity for the modulation of cerebral tolerance to low flow cardiopulmonary bypass and deep hypothermic circulatory arrest.

Key Words: Brain • Cerebral ischemia • Reperfusion • Signal transduction




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
T. Zaitseva, S. Schultz, G. Schears, P. Pastuszko, S. Markowitz, W. Greeley, D. F. Wilson, and A. Pastuszko
Regulation of Brain Cell Death and Survival After Cardiopulmonary Bypass
Ann. Thorac. Surg., December 1, 2006; 82(6): 2247 - 2253.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. M. Sheikh, C. Barrett, N. Villamizar, O. Alzate, S. Miller, J. Shelburne, A. Lodge, J. Lawson, and J. Jaggers
Proteomics of cerebral injury in a neonatal model of cardiopulmonary bypass with deep hypothermic circulatory arrest
J. Thorac. Cardiovasc. Surg., October 1, 2006; 132(4): 820 - 828.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.